Arch Neurosci

Image Credit:Arch Neurosci

Mapping the Central Genes in Bipolar Disorder Pathways: From Data to Diagnosis

Author(s):
Hossein SeidkhaniHossein Seidkhani1, Saeid YaghoubiSaeid Yaghoubi2,*
1Department of Biostatistics, School of Health Ilam University of Medical sciences, Ilam, Iran
2School of Health Ilam University of Medical Sciences, Ilam, Iran

Archives of Neuroscience:Vol. 13, issue 1; e169584
Published online:Jan 31, 2026
Article type:Research Article
Received:Dec 20, 2025
Accepted:Jan 26, 2026
How to Cite:Seidkhani H, Yaghoubi S. Mapping the Central Genes in Bipolar Disorder Pathways: From Data to Diagnosis. Arch Neurosci. 2026;13(1):e169584. doi: https://doi.org/10.5812/ans-169584

Abstract

Background:

Diseases related to the brain and nervous system lead to various complications in patients. One of these diseases is bipolar disorder (BD). Bipolar disorder is a multifaceted disorder that is influenced by various factors, including environment and genetics.

Objectives:

For this reason, this study was conducted with the aim of bioinformatically determining gene biomarkers in BD using biomarker study methods.

Methods:

The methodology began by identifying candidate genes through the triangulation of evidence from animal models, in vitro cell cultures, and in silico predictions. Subsequently, high-throughput gene expression data for these candidates were systematically retrieved from public bioinformatics databases. A crucial data processing step involved rigorous standardization: Expression values from case cohorts were precisely normalized against those from healthy controls. This normalization was essential to mitigate batch effects and ensure that observed differences were reliably attributable to the disease state. This allowed for the robust investigation of the primary research hypotheses.

Results:

The core of the analysis involved assessing the topological importance of these genes within the inferred biological networks. Utilizing five complementary network centrality criteria—namely degree, closeness, radius, betweenness, and most neighboring—a highly conserved set of essential genes was successfully isolated. Crucially, four specific genes: CI3RN, BDNF, PPARGC1A, and TP53, exhibited the highest degree of recurrence and centrality when evaluated across the entirety of the five distinct network analysis methods.

Conclusions:

These findings offer a clear and data-driven mandate to suggest and prioritize complementary validation studies at both the fundamental laboratory/molecular level and the translational clinical level, focusing on their efficacy as refined diagnostic biomarkers for BD.

1. Background

Neurological diseases are a type of disease with significant prevalence that can leave irreparable consequences for the patient, family, and society. The complications caused by neurological diseases include stress, anxiety, reduced life expectancy and general health, and increased care pressure on the caregivers of patients. Consequently, the economic burden resulting from long-term care costs places a major strain on social resources. Therefore, prioritizing early diagnosis and effective therapeutic strategies is essential to mitigate this widespread societal impact (1-4). Psychiatric disorder is a disease related to the brain and nervous system, and is one of the severe mental illnesses that disrupts individual, social, and occupational functioning, placing significant pressure on the patient, family, and care providers (5, 6). Psychiatric disorder is a chronic brain disease with a lifetime prevalence of about one percent. This disease, which places a great health and medical burden on society, leads to disability worldwide (7, 8). Psychiatric disorder is a type of debilitating disease and one of the most important psychiatric diseases, affecting about one percent of people throughout their lives. This disease has many negative effects on the social functioning of sufferers, and the likelihood of the disease being prolonged is very high (9-11). Among people with psychiatric disorder, problems occur in working and long-term memory, attention, social functioning, and processing speed. In an unusual subgroup, the individual may be largely silent, exhibit strange motor behaviors, or display inappropriate anxiety (12). Cognitive deficits are widespread in patients with schizophrenia, and treatment options are limited. Treatment plans for schizophrenia patients include hospitalization, medication, electroconvulsive therapy, and psychosocial therapies such as behavioral, family, group, individual, and social skills training, as well as rehabilitation therapies such as cognitive therapy and physical activity (13, 14). One of the diseases related to the brain and nervous system is bipolar disorder (BD) (15, 16). Bipolar disorder is a chronic and periodic disease with acute attacks, the prevalence of which is reported to be around 2 - 4% during life. This disease has been observed in different age groups, including children, teenagers, and adults. Bipolar disorder at a much younger age causes an increase in hospitalizations, suicides, substance abuse, and behavioral problems (17-19). Bipolar disorder is one of the common psychiatric disorders that has a significant impact on the quality of life and various aspects of a person's emotional, professional, and cognitive performance (20). If the patient suffers from BD, in addition to causing physical and mental problems in the patient, the patient's family members also face basic challenges, including mental disorders such as sleep disorders, depression, tension, and feelings of hunger (21, 22). Various genetic and environmental factors are effective in causing bipolar disorder. One of these factors that can be effective in relation to this disorder and other emotional problems is attachment style (23, 24). Using inappropriate treatments for BD can have serious consequences for the health system. If inappropriate treatment is prescribed and the treatment process is prolonged, treatment costs will increase and lead to the ineffectiveness of the treatment system. In fact, the condition for proper treatment is early diagnosis of the disease (20, 25). In order to diagnose the disease, the factors that have influenced its development must be identified. One of these ways is to conduct bioinformatics studies (26, 27). Bioinformatics is a relatively new field that includes data analysis, modeling of biological phenomena, and the development of algorithms and statistical methods. Bioinformatics has been one of the important research topics in recent years that deals with scientific studies (28). Given the high heritability of diseases, it is likely that molecular genetic methods will reveal the related genes. Unfortunately, gene identification and identification of the location of the gene on the chromosome is a difficult task. In recent years, many efforts have been made to understand biomarkers for their diagnosis, prevention, and treatment (29).

2. Objectives

This study was specifically designed to execute a comprehensive bioinformatics-driven investigation aimed at mapping the critical central genes that govern the complex molecular pathways associated with these debilitating neurological conditions, thereby transitioning from raw data to tangible diagnostic potential. For this reason, this study was conducted with the aim of bioinformatic determination of gene biomarkers in BD.

3. Methods

This biomarker study analytically compared gene expression data from BD patients against a control group.

3.1. Paraphrased Methodology for Bipolar Disorder Gene Network Analysis Study

This study was analytically performed by comparing the gene expression data of all BD patients against a control group, with the primary objective of extracting biomarkers related to network structure.

3.2. Data Acquisition and Candidate Gene Selection

The study population comprised all bipolar patients. Initial network data sources included the NCBI database, SWISS-PROT, and the Diseasome database. Genes involved in the disease were extracted after a comprehensive review of literature and searches across bioinformatics databases such as NCBI, Gene Cards, SWISS-PROT, and Diseasome. Candidate genes were selected only if they were suggested based on evidence from at least one method (in vivo, in vitro, or in silico). Gene expression data for these candidate genes were then collected from standard databases using an algorithm specifically written in MATLAB.

3.3. Data Standardization and Network Construction

To facilitate comparison and test the research hypotheses, the expression data obtained from each group (case and control) were standardized relative to the control group. Subsequently, the gene expression data for all experimental groups were normalized relative to the control group. Following this, gene communication networks were established independently for both the patient cohort and the healthy cohort using MATLAB software.

3.4. Analysis and Biomarker Identification

Advanced descriptive and analytical statistical methods, alongside machine learning methods based on sophisticated bioinformatics algorithms, were utilized to calculate the features of the network data analysis. The topological and structural characteristics of these networks were systematically calculated and compared to identify parameters exhibiting significant divergence between the two groups. These distinctive parameters were then designated as prospective biomarkers.

3.5. Validation and Ethical Compliance

Accuracy assessment and biological validation of both the constructed networks and the proposed biomarkers were performed utilizing the Rectome and Diseasome databases. Comprehensive statistical analyses throughout all stages were executed using R and MATLAB. Furthermore, the necessary permits were obtained from the Ethics Committee under reference number IR.MEDILAM.REC.1402.152 to conduct the study. Obtaining the code of ethics in research from Ilam University of Medical Sciences, observing the principles of confidentiality in publishing articles and reporting data, and adhering to the guidelines issued by the university's research ethics committee were considered as ethical criteria in research.

4. Results

This investigation commenced with the objective of mapping the genomic associations underlying BD and quantifying the network’s essential components. Initially, genes implicated in BD were identified via text mining (as cataloged in Table 1). Subsequently, the expression profiles for these prioritized candidate genes were retrieved from established databases, specifically Entrez Gene and Uniprot. Following data acquisition, the communication network connecting these candidate genes was constructed using the Gephi platform. While mapping the network topology, structural centrality criteria were calculated to ascertain the most essential genes and proteins. Crucially, the edge weights within this constructed network were quantitatively defined based on the corresponding expression levels of the associated genes and proteins (as detailed in Table 2).

Table 1.Bipolar Patients Gene Network Connectivity Score
NumberGene NameGDA Score
1HTR2A0.8
2S100B0.74
3CACNA1C0.7
4ANK30.7
5COMT0.7
6NCAN0.68
7SP40.63
8PLOG0.62
8ADCY20.62
10LMAN2L0.61
11FADS20.61
12BDNF0.6
13SLC6A40.6
14CLOCK0.6
15GSK3B0.6
16NR3C10.6
17DRD10.6
18MTHFR0.6
19GAD10.62
20ITIH10.6
21NDUFV20.6
22GRIN2A0.59
23RELN0.58
24ACE0.57
25GRK30.56
26GRM50.6
Table 2.Relevant Scores for the Protein Connectivity Network of Bipolar Patients
NumberMNCDegreeClosenessRadialityBetweenness
1ACEBDNFBDNFBDNFPPARGC1A
2ADCY2TP53PPARGC1APPARGC1ATP53
3S100BNR3C1TP53TP53BDNF
4DRD1PPARGC1AGSK3BGSK3BGAD1
5NR3C1SLC6A4NR3C1NR3C1NDUFV2
6MTHFRSIRT1SIRT1SIRT1GSK3B
7RELNPER2PER2PER2NDUFA9
8PPARGC1ACOMTCOMTCOMTNDUFB5
9SORT1NDUFA9GAD1GAD1NDUFS3
10SIRT1NDUFB5ACEACECACNA1C

4.1. Determining Critical Nodes (Essential Vertices) via Centrality

The concept of ‘hubs’ in network theory, derived from centrality assessments, is utilized to pinpoint the essential vertices within a structural topology. In the context of biological networks, identifying these hub vertices serves to delineate the most influential components, allowing for the proposition of core genes or proteins as diagnostic biomarkers potentially aiding in disease prognosis or therapeutic targeting.

4.2. Network Structural Parameters Employed

The analysis was based on five distinct graph theoretical metrics:

4.2.1. Maximum Neighborhood Component (MNC)

Defined as the cardinality of the largest connected component associated with a specific vertex (a). The MNC score for vertex a is precisely the size of this largest affiliated component. Based on this metric, the top 10 biomarkers were ranked according to their descending MNC scores.

4.2.2. Degree

Defined as the total number of edges incident to a vertex. This fundamental criterion was applied to rank the most effective biomarkers within the established BD network.

4.2.3. Closeness Centrality

Calculated in a connected network as the reciprocal of the sum of the shortest path distances from a given vertex to all other vertices in the network. Its significance in biological network analysis lies in quantifying a gene’s topological proximity to all other network elements.

Radiality: This metric isolates the vertex exhibiting the shortest maximum distance to its immediate neighbors within its local neighborhood set. The highest radiality scores were calculated for a specific subset of genes.

4.2.4. Betweenness Centrality

This measure quantifies the frequency with which a vertex lies upon the shortest paths connecting any two other vertices. A vertex exhibiting high betweenness centrality is critical for information flow; its removal risks significantly fragmenting overall network connectivity.

4.2.5. Network Representation Context

In the visualized communication network (Figure 1), each node represents a gene, and the communicating edge between nodes signifies a physical or functional interaction substantiated by at least one evidence type (in vivo, in vitro, or in silico study). The final gene scoring was performed based on the GDA criterion.

Communication network between genes in bipolar disorder
Figure 1.

Communication network between genes in bipolar disorder

5. Discussion

In the study of Mohammadi et al., the mean age of patients with BD was 11.8 ± 3.78, and 83.5% of them were urban residents. According to the findings, 0.29% of men and 0.26% of women had BD. Also, the incidence of BD was higher in urban residents than in rural residents. On the other hand, the incidence of BD increased with increasing age (30). In the study by Mohammadi et al., of 3147 patients with mental disorders studied between 2006 and 2010, 3.5% of patients had depressive disorder, 2.6% had BIID disorder, and 6.2% had NOS disorder (30). Bipolar disorder is one of the most important psychiatric diseases that causes educational failure, occupational disability, personality degradation, and disruption of individual, family, and social relationships in sufferers. In addition to the individual's involvement, BD also affects the patient's family, disrupting the structure, function, and duties of the family. Bipolar disorder also increases the problems and psychological burden imposed on families, such as economic problems, emotional and stressful reactions resulting from the need to adapt to the disorder, changes in daily family activities, and restrictions on social activities (31-33). This study aimed to conduct a bioinformatics study of gene biomarkers in BD. Psychiatric disorders are multifactorial disorders that are influenced by multiple genes, environmental factors, and genetic and epigenetic processes. Over the past years, the results of studies have shown that genetic findings in psychiatric disorders can be observed, which can provide important assistance in the diagnosis and treatment of this disease (34-38). Numerous bioinformatics studies have been conducted on various diseases, the results of which are explained below. Masoudi et al. studied the ZBTB16 gene in stem cells and analyzed 100 genes related to the ZBTB16 gene. According to the results, the expression of the ZBTB16 gene was clearly seen, and if the ZBTB16 gene is deleted, some undesirable pathways can be disrupted (39). Khorasani et al. conducted a bioinformatics study on the miR-200 family, which found that the E2F3 gene is a common target of all members of the miR-200 family. Also, in the study of Khorasani et al., miR-200c can interfere in the development of prostate cancer by targeting CDKN1B and miR-429 (40). Based on genome-wide scans, highly susceptible gene loci on other chromosomes have been shown to be involved in the development of schizophrenia. Among them, one of the most important genes involved in this disease is the PRODH gene, located on chromosome 22q11. This gene is highly expressed in the brain and encodes a protein called proline dehydrogenase, which catalyzes the first step in protein degradation (41, 42).

5.1. Conclusions

This study successfully integrated literature-based gene identification with complex network analysis to elucidate the structural underpinnings of BD. Initially, candidate genes related to BD were identified via text mining, yielding connectivity scores for key players such as CLOCK and CACNA1C. Subsequently, expression levels were extracted from public databases to accurately weight the edges within the constructed network using Gephi. This weight assignment ensured that the network topology faithfully represented active biological interactions. Finally, the application of five critical centrality measures—including betweenness and MNC—allowed for the precise ranking and identification of pivotal hub genes that are most critical for maintaining the functional integrity of the BD molecular pathway.

Footnotes

References

  • 1.
    Vasigh A, Tarjoman A, Soltani B, Borji M. The Relationship Between Mindfulness and Self-Compassion with Perceived Pain in Migraine Patients in Ilam, 2018. Archives Neurosci. 2019;6(3). https://doi.org/10.5812/ans.91623.
  • 2.
    Hatefi M, Meisami A, Dalvand A, Borji M. Assessment of Daily Living of Patients with Spinal Cord Injury: A Cross-Sectional Study in Kermanshah. Archives Neurosci. 2021;8(3). https://doi.org/10.5812/ans.117199.
  • 3.
    Khalighi E, Tarjoman A, Abdi A, Borji M. The Prevalence of Delirium in Patients in Iran: a Systematic Review and Meta-analysis. Future Neurology. 2019;14(4). https://doi.org/10.2217/fnl-2018-0044.
  • 4.
    Bonkhoff AK, Coughlan G, Perosa V, Alhadid K, Schirmer MD, Regenhardt RW, et al. Sex differences in age-associated neurological diseases-A roadmap for reliable and high-yield research. Sci Adv. 2025;11(10):eadt9243. [PubMed ID: 40043111]. [PubMed Central ID: PMC11881909]. https://doi.org/10.1126/sciadv.adt9243.
  • 5.
    Sullivan PF, Yao S, Hjerling-Leffler J. Schizophrenia genomics: genetic complexity and functional insights. Nat Rev Neurosci. 2024;25(9):611-24. [PubMed ID: 39030273]. https://doi.org/10.1038/s41583-024-00837-7.
  • 6.
    Kaul I, Sawchak S, Walling DP, Tamminga CA, Breier A, Zhu H, et al. Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry. 2024;81(8):749-56. [PubMed ID: 38691387]. [PubMed Central ID: PMC11063924]. https://doi.org/10.1001/jamapsychiatry.2024.0785.
  • 7.
    Sass L, Feyaerts J. Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept. Schizophr Res. 2024;267:473-86. [PubMed ID: 38693032]. https://doi.org/10.1016/j.schres.2024.03.022.
  • 8.
    Liberona A, Jones N, Zuniga K, Garrido V, Zelada MI, Silva H, et al. Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Schizophrenia and Bipolar Disorder: A Systematic Review. Int J Mol Sci. 2024;25(20). [PubMed ID: 39456983]. [PubMed Central ID: PMC11508575]. https://doi.org/10.3390/ijms252011204.
  • 9.
    Liddle PF, Sami MB. The Mechanisms of Persisting Disability in Schizophrenia: Imprecise Predictive Coding via Corticostriatothalamic-Cortical Loop Dysfunction. Biol Psychiatry. 2025;97(2):109-16. [PubMed ID: 39181388]. https://doi.org/10.1016/j.biopsych.2024.08.007.
  • 10.
    Rodolico A, Aprile SF, Cutrufelli P, Privitera G, Castellano S, Concerto C, et al. Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data-Driven Taxonomy. Clin Drug Investig. 2024;44(9):715-27. [PubMed ID: 39302586]. [PubMed Central ID: PMC11455686]. https://doi.org/10.1007/s40261-024-01391-x.
  • 11.
    Defar S, Abraham Y, Reta Y, Deribe B, Jisso M, Yeheyis T, et al. Health related quality of life among people with mental illness: The role of socio-clinical characteristics and level of functional disability. Front Public Health. 2023;11:1134032. [PubMed ID: 36875411]. [PubMed Central ID: PMC9978447]. https://doi.org/10.3389/fpubh.2023.1134032.
  • 12.
    Taghavilarijani T, Noughani F, Danandehfard S. [The effect of family psychological group training on resilience of the families of schizophrenic patients]. Iran J Psychiatr Nurs. 2019;7(2):83-9. FA.
  • 13.
    Lin J, Chan SK, Lee EH, Chang WC, Tse M, Su WW, et al. Aerobic exercise and yoga improve neurocognitive function in women with early psychosis. NPJ Schizophr. 2015;1(0):15047. [PubMed ID: 27336050]. [PubMed Central ID: PMC4849465]. https://doi.org/10.1038/npjschz.2015.47.
  • 14.
    Karimi F, Nezakat AHM. [Yoga Exercises on Executive Functions among Individuals with Schizophrenia]. J Disability Studie. 2022;12. FA.
  • 15.
    Adler CM, DelBello MP, Strakowski SM. Brain network dysfunction in bipolar disorder. CNS Spectr. 2006;11(4):312-20. quiz 323-4. [PubMed ID: 16641836]. https://doi.org/10.1017/s1092852900020800.
  • 16.
    Miller JN, Black DW. Bipolar Disorder and Suicide: a Review. Curr Psychiatry Rep. 2020;22(2):6. [PubMed ID: 31955273]. https://doi.org/10.1007/s11920-020-1130-0.
  • 17.
    Astill Wright L, Bakstein E, Saunders K, Guo B, Morriss R. Performance of active and passive ambulatory assessment measures and mood monitoring in bipolar disorder: a systematic review. Int J Bipolar Disord. 2026;14(1):4. [PubMed ID: 41575653]. [PubMed Central ID: PMC12852565]. https://doi.org/10.1186/s40345-025-00407-5.
  • 18.
    Marano G, Marzo EM, Sfratta G, Traversi G, Capristo E, Gaetani E, et al. Dietetic Prescriptions in Bipolar Disorder: Nutritional Strategies to Support Mood Stability and Reduce Relapse Risk-A Narrative Review. Life (Basel). 2026;16(1). [PubMed ID: 41598300]. [PubMed Central ID: PMC12843453]. https://doi.org/10.3390/life16010146.
  • 19.
    Clougher D, De Prisco M, Sole B, Montejo L, Serra-Navarro M, Forte MF, et al. Resilience in Bipolar Disorder Compared to Clinical and Non-Clinical Populations: A Systematic Review and Meta-Analysis. Acta Psychiatr Scand. 2026;153(1):6-23. [PubMed ID: 41221725]. [PubMed Central ID: PMC12668893]. https://doi.org/10.1111/acps.70042.
  • 20.
    Nierenberg AA, Agustini B, Kohler-Forsberg O, Cusin C, Katz D, Sylvia LG, et al. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023;330(14):1370-80. [PubMed ID: 37815563]. https://doi.org/10.1001/jama.2023.18588.
  • 21.
    Singh B, Swartz HA, Cuellar-Barboza AB, Schaffer A, Kato T, Dols A, et al. Bipolar disorder. Lancet. 2025;406(10506):963-78. [PubMed ID: 40712624]. [PubMed Central ID: PMC12340982]. https://doi.org/10.1016/S0140-6736(25)01140-7.
  • 22.
    Lane NM, Smith DJ. Bipolar disorder: Diagnosis, treatment and future directions. J R Coll Physicians Edinb. 2023;53(3):192-6. [PubMed ID: 37649414]. https://doi.org/10.1177/14782715231197577.
  • 23.
    Biriaei Najaf Abadi D, Nooein A. [The Effectiveness of Object Relations Psychotherapy on Insecure Attachment Styles of 25-30-year-old Women with Bipolar Disorder]. Iran J Psychiatric Nurs. 2024;11(6):119-28. FA. https://doi.org/10.22034/ijpn.11.6.6.
  • 24.
    Arnold I, Dehning J, Grunze A, Hausmann A. Old Age Bipolar Disorder-Epidemiology, Aetiology and Treatment. Medicina (Kaunas). 2021;57(6). [PubMed ID: 34201098]. [PubMed Central ID: PMC8226928]. https://doi.org/10.3390/medicina57060587.
  • 25.
    Jann MW. Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments. Am Health Drug Benefits. 2014;7(9):489-99. [PubMed ID: 25610528]. [PubMed Central ID: PMC4296286].
  • 26.
    Oresic M, Lotjonen J, Soininen H. Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease. Genome Med. 2009;1(11):83. [PubMed ID: 21092145]. [PubMed Central ID: PMC3016625]. https://doi.org/10.1186/gm204.
  • 27.
    Sole B, Jimenez E, Torrent C, Reinares M, Bonnin CDM, Torres I, et al. Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies. Int J Neuropsychopharmacol. 2017;20(8):670-80. [PubMed ID: 28498954]. [PubMed Central ID: PMC5570032]. https://doi.org/10.1093/ijnp/pyx032.
  • 28.
    Kiani M, Asemi A, Cheshmeh Sohrabi M, Shabani A. [Analysis of bioinformatics research trends available in the Clarivate database]. Health Information Management. 2020;16(6):294-300. FA. https://doi.org/10.22122/him.v16i6.3976.
  • 29.
    Esmaeili F, Zolghadri S. [Bioinformatics analysis of gene expression profile in women with major depressive disorder]. Advances Cognitive Sci. 2021;23(2):85-102. FA.
  • 30.
    Mohammadi MR, Alavi SS, Gharaati Sotoudeh H, Khaleghi A, Ahmadi N, Hooshyari Z, et al. Prevalence and Socio-Demographic Factors of Bipolar Mood Disorders in Children and Adolescents: Identifying the Principal Predictors. Iran Rehabilit J. 2022;20(2):149-60. https://doi.org/10.32598/irj.20.2.910.3.
  • 31.
    Saccaro LF, Delavari F, Van De Ville D, Piguet C. Hippocampal temporal dynamics and spatial heterogeneity unveil vulnerability markers in the offspring of bipolar patients. Bipolar Disord. 2025;27(1):17-27. [PubMed ID: 39135100]. [PubMed Central ID: PMC11848017]. https://doi.org/10.1111/bdi.13487.
  • 32.
    Yi X, Ma M, Wang X, Zhang J, Wu F, Huang H, et al. Joint resting state and structural networks characterize pediatric bipolar patients compared to healthy controls: a multimodal fusion approach. Neuroimage. 2025;312:121225. [PubMed ID: 40252878]. https://doi.org/10.1016/j.neuroimage.2025.121225.
  • 33.
    Rahsepar S, Karizaki GA, Samadi S, Jomehzadeh V, Sadjadi SA, Mohammadpour AH, et al. The Effects of Standard Pharmacotherapy on Oxidative Stress Markers in Bipolar Patients: A Systematic Review. Current Psychiatry Research and Reviews. 2025;21(3):284-95. https://doi.org/10.2174/0126660822277544231207111352.
  • 34.
    Vangal KK, Soman S, Bhandary RP, Praharaj SK. Sleep Quality and Quality of Life in Remitted Bipolar Disorder Patients: A Cross-sectional Comparative Study. Indian J Psychol Med. 2025;47(4):356-61. [PubMed ID: 39564311]. [PubMed Central ID: PMC11572401]. https://doi.org/10.1177/02537176241254722.
  • 35.
    D'Silva S, Jayaprakash P. Minor physical anomalies in patients with bipolar disorder - A cross-sectional study done in a tertiary psychiatric institute. Asian J Psychiatr. 2025;109:104562. [PubMed ID: 40472620]. https://doi.org/10.1016/j.ajp.2025.104562.
  • 36.
    Gilardi C, Martins HC, Levone BR, Bianco AL, Bicker S, Germain PL, et al. miR-708-5p is elevated in bipolar patients and can induce mood disorder-associated behavior in mice. EMBO Rep. 2025;26(8):2121-45. [PubMed ID: 40065182]. [PubMed Central ID: PMC12019553]. https://doi.org/10.1038/s44319-025-00410-y.
  • 37.
    Hatefi M, Vaisi-Raygani A, Borji M, Tarjoman A. Investigating the Relationship between Religious Beliefs with Care Burden, Stress, Anxiety, and Depression in Caregivers of Patients with Spinal Cord Injuries. J Relig Health. 2020;59(4):1754-65. [PubMed ID: 31187306]. https://doi.org/10.1007/s10943-019-00853-3.
  • 38.
    Abdi A, Tarjoman A, Borji M. Prevalence of elder abuse in Iran: a Systematic review and meta-analysis. Asian J Psychiatr. 2019;39:120-7. [PubMed ID: 30616159]. https://doi.org/10.1016/j.ajp.2018.12.005.
  • 39.
    Masoudi M, Azizi H, Gholami D, Khaki A. Investigation of ZBTB16 Gene Expression by Bioinformatics Analysis and Immunocytochemistry and Immunohistochemistry Methods in Embryonic Cells Derived From Spermatogonial Stem Cells of Mouse Testis: A Laboratory Study. J Rafsanjan Univ Med Sci. 2023;22(9):947-62. https://doi.org/10.61186/jrums.22.9.947.
  • 40.
    Khorasani M, Shahbazi S, Mahdian R. [Bioinformatics study of the miR-200 family and the target genes in prostate cancer]. J Health Biomed Info. 2019;5(4):495-506. FA.
  • 41.
    Kahn RS, Sommer IE. The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry. 2015;20(1):84-97. [PubMed ID: 25048005]. [PubMed Central ID: PMC4320288]. https://doi.org/10.1038/mp.2014.66.
  • 42.
    Haidari Kashl S, Rahmanizade S, Ghasemvand F, Maleki M. [Analysis of Polymorphisms in Relation to Schizophrenia Susceptibility]. J Ilam Univ Med Sci. 2013;20(4):192-9. FA.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles